Minireview: Steroid receptor coactivator-3: A multifarious coregulator in mammary gland metastasis

Endocrinology

Volumn 152, Issue 1, 2011, Pages 19-25

  Lydon, John P ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; EPIDERMAL GROWTH FACTOR; FOCAL ADHESION KINASE; ISOPROTEIN; MATRIX METALLOPROTEINASE; PROTEIN P160; STEROID RECEPTOR COACTIVATOR 3; TRANSCRIPTION FACTOR;

BREAST CANCER; BREAST METASTASIS; CANCER CELL; CANCER DIAGNOSIS; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; ONCOGENE; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PROTO ONCOGENE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STROMA; TUMOR CELL; TUMOR GROWTH;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NUCLEAR RECEPTOR COACTIVATOR 3; SIGNAL TRANSDUCTION;

EID: 78650842398     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1012     Document Type: Review

References (69)

1. Gupta GP, Massague J 2006 Cancer metastasis: building a framework. Cell 127:679-695
2. Talmadge JE, Fidler IJ 2010 AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70:5649-5669
3. Fidler IJ 2003 The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3:453-458
4. Poste G, Fidler IJ 1980 The pathogenesis of cancer metastasis. Nature 283:139-146
5. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS 1997 AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968
6. O'Malley BW, McKenna NJ 2008 Coactivators and corepressors: what's in a name? Mol Endocrinol 22:2213-2214
7. Xu J, Wu R C, O'Malley BW 2009 Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9:615-630
8. Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
9. Bai J, Uehara Y, Montell DJ 2000 Regulation of invasive cell behavior by taiman, a Drosophila protein related to AIB1, a steroid receptor coactivator amplifiedinbreast cancer. Cell 103:1047-1058
10. Yao TP, Forman BM, Jiang Z, Cherbas L, Chen JD, McKeown M, Cherbas P, Evans RM 1993 Functional ecdysone receptor is the product of Ec R and Ultraspiracle genes. Nature 366:476-479
11. Montell D J 2001 Command and control: regulatory pathways controlling invasive behavior of the border cells. Mech Dev 105:19-25
12. Yoshida H, Liu J, Samuel S, Cheng W, Rosen D, Naora H 2005 Steroid receptor coactivator-3, a homolog of Taiman that controls cell migration in the Drosophila ovary, regulates migration of human ovarian cancer cells. Mol Cell Endocrinol 245:77-85
13. Qin L, Liao L, Redmond A, Young L, Yuan Y, Chen H, O'Malley BW, Xu J 2008 The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol Cell Biol 28:5937-5950
14. Dennis JW, Granovsky M, Warren CE 1999 Glycoprotein glyco-sylation and cancer progression. Biochim Biophys Acta 1473:21-34
15. Wang S, Yuan Y, Liao L, Kuang SQ, Tien JC, O'Malley BW, Xu J 2009 Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation. Proc Natl Acad Sci USA 106:151-156
16. Bouras T, Southey MC, Venter DJ 2001 Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 61:903-907
17. Fleming FJ, Myers E, Kelly G, Crotty TB, McDermott EW, O'Higgins N J, Hill AD, Young L S 2004 Expressionof SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. J Clin Pathol 57:1069-1074
18. Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Allred DC, Clark GM, Schiff R 2003 Roleofthe estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in ta-moxifen resistance in breast cancer. J Natl Cancer Inst 95:353-361
19. Slamon D J, Clark G M, Wong S G, Levin W J, Ullrich A, McGuire W L 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182
20. Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, Schiff R 2004 Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J Natl Cancer Inst 96:926-935
21. Lahusen T, Fereshteh M, Oh A, Wellstein A, Riegel AT 2007 Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. Cancer Res 67:7256-7265
22. Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y, Young LS 2005 Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCo R in breast cancer. Clin Cancer Res 11:2111-2122
23. Galang CK, Garcia-Ramirez J, Solski PA, Westwick JK, Der CJ, Neznanov NN, Oshima RG, Hauser CA 1996 Oncogenic Neu/Erb B-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J Biol Chem 271:7992-7998
24. Wasylyk B, Hahn SL, Giovane A 1993 The Ets family of transcription factors. Eur J Biochem 211:7-18
25. Qin L, Liu Z, Chen H, Xu J 2009 The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Res 69:3819-3827
26. Hurst H C 2001 Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment. Breast Cancer Res 3:395-398
27. Shepherd T, Hassell JA 2001 Role of Ets transcription factors in mammary gland development and oncogenesis. J Mammary Gland Biol Neoplasia 6:129-140
28. Kirkegaard T, McGlynn LM, Campbell FM, Muller S, Tovey SM, Dunne B, Nielsen KV, Cooke TG, Bartlett JM 2007 Amplified in breast cancer 1inhuman epidermal growth factor receptor-positive tumors oftamoxifen-treated breast cancer patients. Clin Cancer Res 13:1405-1411
29. Redmond AM, Bane FT, Stafford AT, McIlroy M, Dillon MF, Crotty TB, Hill AD, Young LS 2009 Coassociation of estrogen receptor and p160 proteins predicts resistance toendocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence. Clin Cancer Res 15:2098-2106
30. Fereshteh MP, Tilli MT, Kim SE, Xu J, O'Malley BW, Wellstein A, Furth PA, Riegel AT 2008 The nuclear receptor coactivator amplified in breast cancer-1 isrequired for Neu (Erb B2/HER2) activation, signaling, and mammary tumorigenesis in mice. Cancer Res 68: 3697-3706
31. Tomaskovic-Crook E, Thompson EW, Thiery JP 2009 Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res 11: 213
32. Lochter A, Sternlicht MD, Werb Z, Bissell M J 1998 The significance of matrix metalloproteinases during early stages of tumor progression. Ann NY Acad Sci 857:180-193
33. Li LB, Louie MC, Chen HW, Zou JX 2008 Proto-oncogene ACTR/AIB1 promotes cancer cell invasion by up-regulating specific matrix metalloproteinase expression. Cancer Lett 261:64-73
34. Yan J, Erdem H, Li R, Cai Y, Ayala G, Ittmann M, Yu-Lee LY, Tsai SY, Tsai M J 2008 Steroid receptorcoactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res 68:5460-5468
35. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg R A 2004 Twist, a master regulatorofmorphogenesis, playsanessential roleintumor metastasis. Cell 117:927-939
36. Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J, Aaronson SA 1987 Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51:1063-1070
37. Bokoch GM 2003 Biology of the p21-activated kinases. Annu Rev Biochem 72:743-781
38. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD 2000 FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2:249-256
39. Goi T, Shipitsin M, Lu Z, Foster DA, Klinz SG, Feig LA 2000 An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity. EMBO J 19:623-630
40. Galisteo ML, Chernoff J, Su YC, Skolnik EY, Schlessinger J 1996 The adaptor protein Nck links receptor tyrosine kinases with the serine-threonine kinase Pak1. J Biol Chem 271:20997-21000
41. Schlaepfer D D, Mitra S K 2004 Multiple connections linkFAKtocell motility and invasion. Curr Opin Genet Dev 14:92-101
42. Eide BL, Turck CW, Escobedo JA 1995 Identification of Tyr-397 as the primary site of tyrosine phosphorylation and pp60src association in the focal adhesion kinase, pp125FAK. Mol Cell Biol 15: 2819-2827
43. Calalb MB, Polte TR, Hanks SK 1995 Tyrosine phosphorylation of focal adhesion kinaseatsitesinthe catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 15:954-963
44. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P 1994 Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372:786-791
45. Westhoff MA, Serrels B, Fincham VJ, Frame MC, Carragher NO 2004 SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamicstosurvival signaling. Mol Cell Biol 24:8113-8133
46. Mitra S K, Schlaepfer D D 2006 Integrin-regulated FAK-Srcsignaling in normal and cancer cells. Curr Opin Cell Biol 18:516-523
47. Kaneda T, Sonoda Y, Ando K, Suzuki T, Sasaki Y, Oshio T, Tago M, Kasahara T 2008 Mutation of Y925F in focal adhesion kinase (FAK) suppresses melanoma cell proliferation and metastasis. Cancer Lett 270:354-361
48. Long W, Yi P, Amazit L, La Marca HL, Ashcroft F, Kumar R, Man-cini MA, Tsai SY, Tsai MJ, O'Malley BW 2010 SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration. Mol Cell 37:321-332
49. Reiter R, Wellstein A, Riegel AT 2001 An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is over-expressed in breast cancer. J Biol Chem 276:39736-39741
50. Reiter R, Oh AS, Wellstein A, Riegel AT 2004 Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic li-gands with different intrinsic activity. Oncogene 23:403-409
51. Lamagna C, Aurrand-Lions M, Imhof BA 2006 Dual role of mac-rophages in tumor growth and angiogenesis. J Leukoc Biol 80:705-713
52. McKenna NJ, O'Malley BW 2002 Minireview: nuclear receptor coactivators-an update. Endocrinology 143:2461-2465
53. Del Monte U 2009 Does the cell number 10(9) stillreally fit onegram of tumor tissue? Cell Cycle 8: 505-506
54. Luo M, Guan JL 2010 Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett 289:127-139
55. Shibue T, Weinberg RA 2009 Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 106:10290-10295
56. Han SJ, Lonard DM, O'Malley BW 2009 Multi-modulation of nuclear receptor coactivators through posttranslational modifications. Trends Endocrinol Metab 20:8-15
57. Li S, Shang Y 2007 Regulation of SRC family coactivators by post-translational modifications. Cell Signal 19:1101-1112
58. York B, Yu C, Sagen JV, Liu Z, Nikolai BC, Wu RC, Finegold M, Xu J, O'Malley BW 2010 Reprogramming the posttranslational code ofSRC-3 confers aswitch in mammalian systems biology. Proc Natl Acad Sci USA 107:11122-11127
59. Li C, Wu RC, Amazit L, Tsai SY, Tsai MJ, O'Malley BW 2007 Specific Amino Acid Residues in the Basic Helix-Loop-Helix Domain of SRC-3 Are Essential for Its Nuclear Localization and Pro-teasome-Dependent Turnover. Mol Cell Biol 27:1296-1308
60. Li X, Amazit L, Long W, Lonard DM, Monaco JJ, O'Malley BW 2007 Ubiquitin-and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell 26:831-842
61. Wu RC, Feng Q, Lonard DM, O'Malley BW 2007 SRC-3 coacti-vator functional lifetime is regulated by a phospho-dependent ubiq-uitin time clock. Cell 129:1125-1140
62. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, Hannon GJ, Stebbing J 2009 The estrogen receptor-alpha-induced mi-croRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA 106:15732-15737
63. Hossain A, Kuo MT, Saunders G F 2006 Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26:8191-8201
64. Cullen B R 2004 Transcription andprocessingofhuman microRNA precursors. Mol Cell 16:861-865
65. Yu Z, Baserga R, Chen L, Wang C, Lisanti MP, Pestell RG 2010 microRNA, cell cycle, and human breast cancer. Am J Pathol 176: 1058-1064
66. Dykxhoorn DM 2010 Micro RNAs and metastasis: little RNAs go a long way. Cancer Res 70:6401-6406
67. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson A L, Weinberg R A 2009 A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137:1032-1046
68. Mukherjee A, Soyal S M, Fernandez-Valdivia R, Gehin M, Chambon P, De Mayo FJ, Lydon JP, O'Malley BW 2006 Steroid receptor co-activator 2 is critical for progesterone-dependent uterine function and mammarymorphogenesisinthemouse.Mol Cell Biol 26:6571-6583
69. Mukherjee A, Amato P, Allred DC, De Mayo FJ, Lydon JP 2007 Steroid receptor coactivator 2 is required for female fertility and mammary morphogenesis: insights from the mouse, relevanceto the human. Nucl Recept Signal Nov 30; 5:e011